Vaccination against the polymorphic epithelial mucine MUC1 commonly overexpressed in breast cancer;Vaccination contre les cellules tumorales mammaires exprimant la mucine MUC1

Bulletin du Cancer

Volumn 84, Issue 1, 1997, Pages 61-64

  Scholl, Susy Marie ^a   Pouillart, Pierre ^a  

^a INSTITUT CURIE   (France)

Author keywords

breast cancer; cellular immunity; clinical trials; humoral immunity; immune tolerance; immunotherapy; MUC1; polymorphic epithelial mucin (PEM); Th 1; Th 2

Indexed keywords

CA 15-3 ANTIGEN; CANCER VACCINE; MUCIN; TUMOR ANTIGEN;

BREAST CANCER; CANCER IMMUNOTHERAPY; FEMALE; HUMAN; REVIEW;

ANIMALS; ANTIBODY FORMATION; BREAST NEOPLASMS; CA-15-3 ANTIGEN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOTHERAPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RATS; T-LYMPHOCYTES; VACCINATION; VACCINES, SYNTHETIC;

EID: 0031049070     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Acres RB, Hareuveni M, Balloul JM, et al. Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumours bearing the MUC1 antigen. J Immunother 1993; 14: 136-43.
2. Barnd DL, Lan MS, Metzgar RS, et al. Specific, major histocompatibility complex-unrestricted recognition of tumour-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 1989; 86: 7159-04.
3. Brockhausen I, Yang JM, Burchell J, et al. Mechanism underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem 1995; 233: 607-18.
4. Burchell J, Gendler SJ, Taylor-Papadimitriou J, et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res 1987; 47: 5476-82.
5. Domenech N, Finn OJ. In vitro studies of MHC-restricted recognition of a peptide from the MUC1 tandem repeat domain by CTL. FASEB J 1995; 9: A1023.
6. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I, Sobol RE. Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci USA 1996; 93 (7): 2909-14.
7. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of the human tumour-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 15286-93.
8. Gourevitch MM, Mensdorff-Pouilly S, von Litvinov SV, et al. Polymorphic epithelial mucin (MUC1)-containing circulating immune complexes in carcinoma patients. Br J Cancer 1995; 72: 934-8.
9. Graham RA, Burchell J, Taylor-Papadimitriou J. The polymorphic epithelial mucin: potential as an immunogen for a cancer vaccine. Cancer Immunol Immunother 1996a; 42: 71-80.
10. Graham RA, Burchell JM, Beverley P, et al. Intramuscular immunization with MUC1 cDNA can protect C57 mice challenged with MUC1 expressing syngeneic mouse tumour cells. Int J Cancer 1996b (in press).
11. Granowska M, Mather SJ, Joblin T, et al. Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Int J Biol Markers 1990; 5: 89-96.
12. Hird V, Maraveyas A, Snook D, et al. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br J Cancer 1993; 68: 403-6.
13. Jerome KR, Barnd DL, Bendt KM, et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Research 1991; 51: 2908-16.
14. Miles DW, Happerfield LC, Smith P, et al. Expression of sialyl-Tn predicts the utility of adjuvant chemotherapy in node positive breast cancer. Br J Cancer 1994; 70: 1272-5.
15. Scholl SM, Pallud C, Beuvon F, et al. Anti-colony stimulating factor-1 antibody staining in primary breast adenoarcinomas correlates with marked inflammatory cell infiltrates and with prognosis. J Nat Cancer Inst 1994; 86: 120-6.
16. Taylor-Papadimitriou J, Peat N, Graham R, Burchell J. Aberrant glycosylation of the MUC1 gene product in adenocarcinomas: implications for immunotherapy. In: Bock K, Clausen H, eds. Complex carbohydrates in drug research. Munksgaard: Copenhagen 1994; 382-93.
17. Xing PX, Michael M, Apostopoulos V, et al. Phase I study of synthetic MUC1 peptides in breast cancer. Int J Oncol 1995; 6: 1283-9.